Fig. 4: Renal response.

Complete and durable (≥60 days) renal responses in patients with eGFR <50 mL/min/1.73 m² at baseline in the Isa-Pd and Pd arms. eGFR estimated glomerular filtration rate, Isa-Pd isatuximab, pomalidomide, and dexamethasone, Pd pomalidomide and dexamethasone.